Home LiteratureArticle Details
PMID: 20644536 Published · ppublish English Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't

Cell type of origin influences the molecular and functional properties of mouse induced pluripotent stem cells.

Nature biotechnology ·Vol. 28 ·No. 8 ·2010-08-00 ·Pages 848-55

Polo JM, Liu S, Figueroa ME, Kulalert W, Eminli S, Tan KY, Apostolou E, Stadtfeld M, Li Y, Shioda T, Natesan S, Wagers AJ, Melnick A, Evans T, Hochedlinger K

Abstract

Induced pluripotent stem cells (iPSCs) have been derived from various somatic cell populations through ectopic expression of defined factors. It remains unclear whether iPSCs generated from different cell types are molecularly and functionally similar. Here we show that iPSCs obtained from mouse fibroblasts, hematopoietic and myogenic cells exhibit distinct transcriptional and epigenetic patterns. Moreover, we demonstrate that cellular origin influences the in vitro differentiation potentials of iPSCs into embryoid bodies and different hematopoietic cell types. Notably, continuous passaging of iPSCs largely attenuates these differences. Our results suggest that early-passage iPSCs retain a transient epigenetic memory of their somatic cells of origin, which manifests as differential gene expression and altered differentiation capacity. These observations may influence ongoing attempts to use iPSCs for disease modeling and could also be exploited in potential therapeutic applications to enhance differentiation into desired cell lineages.

MeSH Terms
Animals B-Lymphocytes/cytology Cell Differentiation Cell Lineage Cells, Cultured Embryoid Bodies/cytology,metabolism Epigenomics Fibroblasts/cytology,metabolism Gene Expression Profiling Hematopoietic Stem Cells/cytology,metabolism Induced Pluripotent Stem Cells/cytology,metabolism Mice Muscle, Skeletal/cytology Stem Cells/cytology Transcription, Genetic
Authors & Affiliations
15 authors, click to expand affiliations / ORCID
Polo Jose M
Howard Hughes Medical Institute and Department of Stem Cell and Regenerative Biology, Harvard University and Harvard Medical School, Cambridge, Massachusetts, USA.
Liu Susanna
Figueroa Maria Eugenia
Kulalert Warakorn
Eminli Sarah
Tan Kah Yong
Apostolou Effie
Stadtfeld Matthias
Li Yushan
Shioda Toshi
Natesan Sridaran
Wagers Amy J
Melnick Ari
Evans Todd
Hochedlinger Konrad
References (43)
43 references, click to expand
  1. Role of the murine reprogramming factors in the induction of pluripotency.
    Cell. 2009 Jan 23;136(2):364-77 PMID: 19167336
  2. Variation in the safety of induced pluripotent stem cell lines.
    Nat Biotechnol. 2009 Aug;27(8):743-5 PMID: 19590502
  3. Induced pluripotent stem cells generated from patients with ALS can be differentiated into motor neurons.
    Science. 2008 Aug 29;321(5893):1218-21 PMID: 18669821
  4. Reprogramming of pancreatic beta cells into induced pluripotent stem cells.
    Curr Biol. 2008 Jun 24;18(12):890-4 PMID: 18501604
  5. Defining molecular cornerstones during fibroblast to iPS cell reprogramming in mouse.
    Cell Stem Cell. 2008 Mar 6;2(3):230-40 PMID: 18371448
  6. Persistent donor cell gene expression among human induced pluripotent stem cells contributes to differences with human embryonic stem cells.
    PLoS One. 2010 Feb 01;5(2):e8975 PMID: 20126639
  7. Telomeres acquire embryonic stem cell characteristics in induced pluripotent stem cells.
    Cell Stem Cell. 2009 Feb 6;4(2):141-54 PMID: 19200803
  8. Promotion of reprogramming to ground state pluripotency by signal inhibition.
    PLoS Biol. 2008 Oct 21;6(10):e253 PMID: 18942890
  9. Hemangioblastic derivatives from human induced pluripotent stem cells exhibit limited expansion and early senescence.
    Stem Cells. 2010 Apr;28(4):704-12 PMID: 20155819
  10. Dissecting direct reprogramming through integrative genomic analysis.
    Nature. 2008 Jul 3;454(7200):49-55 PMID: 18509334
  11. Induced pluripotent stem cells and embryonic stem cells are distinguished by gene expression signatures.
    Cell Stem Cell. 2009 Jul 2;5(1):111-23 PMID: 19570518
  12. Generation of germline-competent induced pluripotent stem cells.
    Nature. 2007 Jul 19;448(7151):313-7 PMID: 17554338
  13. A drug-inducible transgenic system for direct reprogramming of multiple somatic cell types.
    Nat Biotechnol. 2008 Aug;26(8):916-24 PMID: 18594521
  14. Induced pluripotent stem cells from a spinal muscular atrophy patient.
    Nature. 2009 Jan 15;457(7227):277-80 PMID: 19098894
  15. Reprogramming of human somatic cells to pluripotency with defined factors.
    Nature. 2008 Jan 10;451(7175):141-6 PMID: 18157115
  16. Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors.
    Cell. 2006 Aug 25;126(4):663-76 PMID: 16904174
  17. Incomplete reactivation of Oct4-related genes in mouse embryos cloned from somatic nuclei.
    Development. 2003 Apr;130(8):1673-80 PMID: 12620990
  18. Aberrant silencing of imprinted genes on chromosome 12qF1 in mouse induced pluripotent stem cells.
    Nature. 2010 May 13;465(7295):175-81 PMID: 20418860
  19. Differentiation stage determines potential of hematopoietic cells for reprogramming into induced pluripotent stem cells.
    Nat Genet. 2009 Sep;41(9):968-76 PMID: 19668214
  20. Efficient and rapid generation of induced pluripotent stem cells from human keratinocytes.
    Nat Biotechnol. 2008 Nov;26(11):1276-84 PMID: 18931654
  21. Generation of induced pluripotent stem cells from human blood.
    Blood. 2009 May 28;113(22):5476-9 PMID: 19299331
  22. Epigenetic memory of active gene transcription is inherited through somatic cell nuclear transfer.
    Proc Natl Acad Sci U S A. 2005 Feb 8;102(6):1957-62 PMID: 15684086
  23. Generation of human induced pluripotent stem cells from dermal fibroblasts.
    Proc Natl Acad Sci U S A. 2008 Feb 26;105(8):2883-8 PMID: 18287077
  24. Reprogramming of neural progenitor cells into induced pluripotent stem cells in the absence of exogenous Sox2 expression.
    Stem Cells. 2008 Oct;26(10):2467-74 PMID: 18635867
  25. Highly efficient, functional engraftment of skeletal muscle stem cells in dystrophic muscles.
    Cell. 2008 Jul 11;134(1):37-47 PMID: 18614009
  26. Technical challenges in using human induced pluripotent stem cells to model disease.
    Cell Stem Cell. 2009 Dec 4;5(6):584-95 PMID: 19951687
  27. A bivalent chromatin structure marks key developmental genes in embryonic stem cells.
    Cell. 2006 Apr 21;125(2):315-26 PMID: 16630819
  28. Parkinson's disease patient-derived induced pluripotent stem cells free of viral reprogramming factors.
    Cell. 2009 Mar 6;136(5):964-77 PMID: 19269371
  29. Modelling pathogenesis and treatment of familial dysautonomia using patient-specific iPSCs.
    Nature. 2009 Sep 17;461(7262):402-6 PMID: 19693009
  30. Neural differentiation of human induced pluripotent stem cells follows developmental principles but with variable potency.
    Proc Natl Acad Sci U S A. 2010 Mar 2;107(9):4335-40 PMID: 20160098
  31. Generation of pluripotent stem cells from adult mouse liver and stomach cells.
    Science. 2008 Aug 1;321(5889):699-702 PMID: 18276851
  32. Oct4 distribution and level in mouse clones: consequences for pluripotency.
    Genes Dev. 2002 May 15;16(10):1209-19 PMID: 12023300
  33. Sox2 is dispensable for the reprogramming of melanocytes and melanoma cells into induced pluripotent stem cells.
    J Cell Sci. 2009 Oct 1;122(Pt 19):3502-10 PMID: 19723802
  34. A combined chemical and genetic approach for the generation of induced pluripotent stem cells.
    Cell Stem Cell. 2008 Jun 5;2(6):525-8 PMID: 18522845
  35. A high-efficiency system for the generation and study of human induced pluripotent stem cells.
    Cell Stem Cell. 2008 Sep 11;3(3):340-5 PMID: 18786420
  36. Epigenetic memory of an active gene state depends on histone H3.3 incorporation into chromatin in the absence of transcription.
    Nat Cell Biol. 2008 Jan;10(1):102-9 PMID: 18066050
  37. Pluripotent stem cells induced from adult neural stem cells by reprogramming with two factors.
    Nature. 2008 Jul 31;454(7204):646-50 PMID: 18594515
  38. Direct reprogramming of terminally differentiated mature B lymphocytes to pluripotency.
    Cell. 2008 Apr 18;133(2):250-64 PMID: 18423197
  39. Induction of pluripotent stem cells from adult human fibroblasts by defined factors.
    Cell. 2007 Nov 30;131(5):861-72 PMID: 18035408
  40. Disease-specific induced pluripotent stem cells.
    Cell. 2008 Sep 5;134(5):877-86 PMID: 18691744
  41. Epigenetic memory in induced pluripotent stem cells.
    Nature. 2010 Sep 16;467(7313):285-90 PMID: 20644535
  42. Induced pluripotent stem cell lines derived from human somatic cells.
    Science. 2007 Dec 21;318(5858):1917-20 PMID: 18029452
  43. A reprogrammable mouse strain from gene-targeted embryonic stem cells.
    Nat Methods. 2010 Jan;7(1):53-5 PMID: 20010832
Article Info
Journal
Nature biotechnology
Abbr.
Nat Biotechnol
ISSN
1546-1696
Published
2010-08-00
Epub
2010-00-19
Pages
848-55
Language
English
Region
United States
NLM ID
9604648
PMCID
PMC3148605
Subset
IM
Grants
Howard Hughes Medical Institute · United States
NHLBI NIH HHS · R01 HL056182 · United States
NIDDK NIH HHS · P30 DK036836 · United States
NIH HHS · DP2 OD004345 · United States
NHLBI NIH HHS · HL056182 · United States
NHLBI NIH HHS · R37 HL056182 · United States
NICHD NIH HHS · R01 HD058013 · United States
NHLBI NIH HHS · R37 HL056182-15 · United States
NIDDK NIH HHS · P30DK036836 · United States
NIH HHS · DP2 OD004345-01 · United States
Corrections
CommentIn
CommentIn
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com